Characterization of the virulence of Cryptococcus neoformans strains in an insect model

References

• Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16:837-74, v-vi; PMID:12512184; http://dx.doi.org/10.1016/S0891-5520(02)00036-3
   PubMed Web of Science ®Google Scholar
• Mandal P, Banerjee U, Casadevall A, Nosanchuk JD. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J Clin Microbiol 2005; 43:4766-72; PMID:16145139; http://dx.doi.org/10.1128/JCM.43.9.4766-4772.2005
   PubMed Web of Science ®Google Scholar
• Alvarez M, Burn T, Luo Y, Pirofski LA, Casadevall A. The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. BMC Microbiol 2009; 9:51; PMID:19265539; http://dx.doi.org/10.1186/1471-2180-9-51
   PubMed Web of Science ®Google Scholar
• Gilbert AS, Wheeler RT, May RC. Fungal Pathogens: Survival and Replication within Macrophages. Cold Spring Harb Perspect Med 2014; 5:a019661; PMID:25384769; http://dx.doi.org/10.1101/cshperspect.a019661
   PubMed Web of Science ®Google Scholar
• Sabiiti W, May RC, Pursall ER. Experimental models of cryptococcosis. International J Microbiol 2012; 2012:626745; http://dx.doi.org/10.1155/2012/626745
   PubMedGoogle Scholar
• Carroll SF, Guillot L, Qureshi ST. Mammalian model hosts of cryptococcal infection. Comparative Med 2007; 57:9-17
   PubMed Web of Science ®Google Scholar
• Goldman DL, Casadevall A, Cho Y, Lee SC. Cryptococcus neoformans meningitis in the rat. Lab Invest 1996; 75:759-70; PMID:8973471
   PubMed Web of Science ®Google Scholar
• Casadevall A, Steenbergen JN, Nosanchuk JD. 'Ready made' virulence and ‘dual use’ virulence factors in pathogenic environmental fungi–the Cryptococcus neoformans paradigm. Curr Opinion Microbiol 2003; 6:332-7; http://dx.doi.org/10.1016/S1369-5274(03)00082-1
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci USA 2002; 99:15675-80; PMID:12438649; http://dx.doi.org/10.1073/pnas.232568599
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA 2001; 98:15245-50; PMID:11742090; http://dx.doi.org/10.1073/pnas.261418798
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect Immun 2003; 71:4862-72; PMID:12933827; http://dx.doi.org/10.1128/IAI.71.9.4862-4872.2003
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-50; PMID:15972469; http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005
   PubMed Web of Science ®Google Scholar
• Perfect JR, Casadevall A. The history of Cryptococcus and Cryptococcosis. Cryptococcus: from human pathogen to model yeast Washington, DC: ASM Press pp 2011:17-26
   Google Scholar
• Bouklas T, Pechuan X, Goldman DL, Edelman B, Bergman A, Fries BC. Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis. MBio 2013; 4:e00455-13; PMID:23943761; http://dx.doi.org/10.1128/mBio.00455-13
   PubMed Web of Science ®Google Scholar
• Sabiiti W, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, Jarvis JN, Gilbert AS, Fisher MC, Harrison TS, et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest 2014; 124:2000-8; PMID:24743149; http://dx.doi.org/10.1172/JCI72950
   PubMed Web of Science ®Google Scholar
• Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000; 27:163-9; PMID:10640612; http://dx.doi.org/10.1111/j.1574-695X.2000.tb01427.x
   PubMed Web of Science ®Google Scholar
• Firacative C, Duan S, Meyer W. Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattii. PloS One 2014; 9:e105076; PMID:25133687; http://dx.doi.org/10.1371/journal.pone.0105076
   PubMed Web of Science ®Google Scholar
• Garcia-Solache MA, Izquierdo-Garcia D, Smith C, Bergman A, Casadevall A. Fungal virulence in a lepidopteran model is an emergent property with deterministic features. MBio 2013; 4:e00100-13; PMID:23631914; http://dx.doi.org/10.1128/mBio.00100-13
   PubMed Web of Science ®Google Scholar
• Ronald J, Tang H, Brem RB. Genomewide evolutionary rates in laboratory and wild yeast. Genetics 2006; 174:541-4; PMID:16816417; http://dx.doi.org/10.1534/genetics.106.060863
   PubMed Web of Science ®Google Scholar
• Desalermos A, Tan X, Rajamuthiah R, Arvanitis M, Wang Y, Li D, Kourkoumpetis TK, Fuchs BB, Mylonakis E. A multi-host approach for the systematic analysis of virulence factors in Cryptococcus neoformans. J Infect Dis 2015; 211:298-305; PMID:25114160; http://dx.doi.org/10.1093/infdis/jiu441
   PubMed Web of Science ®Google Scholar
• Jain N, Li L, Hsueh YP, Guerrero A, Heitman J, Goldman DL, Fries BC. Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans. Infect Immun 2009; 77:128-40; PMID:18955480; http://dx.doi.org/10.1128/IAI.01079-08
   PubMed Web of Science ®Google Scholar
• Delaney JR, Murakami CJ, Olsen B, Kennedy BK, Kaeberlein M. Quantitative evidence for early life fitness defects from 32 longevity-associated alleles in yeast. Cell Cycle 2011; 10:156-65; PMID:21191185; http://dx.doi.org/10.4161/cc.10.1.14457
   PubMed Web of Science ®Google Scholar
• Stumpferl SW, Brand SE, Jiang JC, Korona B, Tiwari A, Dai J, Seo JG, Jazwinski SM. Natural genetic variation in yeast longevity. Genome Res 2012; 22:1963-73; PMID:22955140; http://dx.doi.org/10.1101/gr.136549.111
   PubMed Web of Science ®Google Scholar
• Jain N, Cook E, Xess I, Hasan F, Fries D, Fries BC. Isolation and characterization of senescent Cryptococcus neoformans and implications for phenotypic switching and pathogenesis in chronic cryptococcosis. Eukaryotic cell 2009; 8:858-66; PMID:19411622; http://dx.doi.org/10.1128/EC.00017-09
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med 1991; 173:793-800; PMID:1672543; http://dx.doi.org/10.1084/jem.173.4.793
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Lee S, Mukherjee J, Scharff MD, Casadevall A. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun 1994; 62:1079-88; PMID:8112842
   PubMed Web of Science ®Google Scholar
• Jain N, Wickes BL, Keller SM, Fu J, Casadevall A, Jain P, Ragan MA, Banerjee U, Fries BC. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J Clin Microbiol 2005; 43:5733-42; PMID:16272511; http://dx.doi.org/10.1128/JCM.43.11.5733-5742.2005
   PubMed Web of Science ®Google Scholar
• Casadevall A, Spitzer ED, Webb D, Rinaldi MG. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 1993; 37:1383-6; PMID:8328793; http://dx.doi.org/10.1128/AAC.37.6.1383
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Edman JC, Wickes BL. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 1992; 60:602-5; PMID:1730495
   PubMed Web of Science ®Google Scholar